In transgenic mice overexpressing the mutated form of synuclein associated with PD (A53T), we confirmed this perspective, highlighting both anti-amyloidogenic and anti-inflammatory activity as essential in countering the pathological spread in PD [137], [138]. Here, SNCA is linked to Parkinson disease.